Advertisement

Pharmacy

Drugmakers increased the price of 60 products August — a sharp decline from July, which saw 110 price increases, according to a Wells Fargo drug-pricing report.

Despite public outrage over the high cost of insulin and drugmaker promises to halt price increases, they continued to climb from 2017 to 2018, according to a GoodRx analysis.

Advertisement

In an effort to increase drug price transparency, the Senate passed a bill that would ban Medicare insurers from writing gag clauses into their contracts with pharmacists, according to The Washington Examiner.

To find financial wiggle room to compete with larger rivals, Bayer is considering job cuts and outsourcing, a person familiar with the discussion told Reuters.

Camber Pharmaceuticals issued a voluntary recall of one lot of its Montelukast sodium tablets after the bottles were found to contain the wrong drug.

Advertisement